Pharmacologically induced myocardial ischemia: A comparison of dobutamine and dipyridamole

Douglas S. Segar, Thomas Ryan, Stephen Sawada, Michael Johnson, Harvey Feigenbaum

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The purpose of our study was to compare the ability of dobutamine and dipyridamole infusion to induce myocardial ischemia. In a population of 16 anesthetized open-chest swine, a coronary artery stenosis sufficient to abolish the hyperemic response to a 15-second total occlusion was created. Heart rate, systolic blood pressure, and dP/dt were recorded. Myocardial segment shortening was determined by sonomicrometry in all animals. In a subset of seven animals regional myocardial blood flow was measured by injection of radiolabeled microspheres. Dipyridamole was infused according to a high-dose protocol. After a washout period and reestablishment of a baseline state, dobutamine was infused incrementally. There was no significant difference between the baseline states. Dipyridamole did not affect heart rate but did significantly decrease blood pressure and rate-pressure product. Myocardial segment shortening decreased in the ischemic zone by 0.07±0.08 (p=0.004). Dobutamine infusion significantly increased heart rate, blood pressure, and rate-pressure product. Myocardial segment shortening in the ischemic zone decreased by 0.17±0.09 (p<0.001). Dobutamine decreased blood flow in the ischemic zone relative to baseline. Both dobutamine and dipyridamole infusion resulted in myocardial ischemia. The magnitude of the ischemic response is greater for dobutamine than for dipyridamole.

Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalJournal of the American Society of Echocardiography
Volume8
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Dobutamine
Dipyridamole
Myocardial Ischemia
Blood Pressure
Heart Rate
Pressure
Coronary Stenosis
Regional Blood Flow
Microspheres
Swine
Thorax
Injections
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Pharmacologically induced myocardial ischemia : A comparison of dobutamine and dipyridamole. / Segar, Douglas S.; Ryan, Thomas; Sawada, Stephen; Johnson, Michael; Feigenbaum, Harvey.

In: Journal of the American Society of Echocardiography, Vol. 8, No. 1, 1995, p. 9-14.

Research output: Contribution to journalArticle

@article{df87d0fc71454a4eaa035ec1f9aa7ade,
title = "Pharmacologically induced myocardial ischemia: A comparison of dobutamine and dipyridamole",
abstract = "The purpose of our study was to compare the ability of dobutamine and dipyridamole infusion to induce myocardial ischemia. In a population of 16 anesthetized open-chest swine, a coronary artery stenosis sufficient to abolish the hyperemic response to a 15-second total occlusion was created. Heart rate, systolic blood pressure, and dP/dt were recorded. Myocardial segment shortening was determined by sonomicrometry in all animals. In a subset of seven animals regional myocardial blood flow was measured by injection of radiolabeled microspheres. Dipyridamole was infused according to a high-dose protocol. After a washout period and reestablishment of a baseline state, dobutamine was infused incrementally. There was no significant difference between the baseline states. Dipyridamole did not affect heart rate but did significantly decrease blood pressure and rate-pressure product. Myocardial segment shortening decreased in the ischemic zone by 0.07±0.08 (p=0.004). Dobutamine infusion significantly increased heart rate, blood pressure, and rate-pressure product. Myocardial segment shortening in the ischemic zone decreased by 0.17±0.09 (p<0.001). Dobutamine decreased blood flow in the ischemic zone relative to baseline. Both dobutamine and dipyridamole infusion resulted in myocardial ischemia. The magnitude of the ischemic response is greater for dobutamine than for dipyridamole.",
author = "Segar, {Douglas S.} and Thomas Ryan and Stephen Sawada and Michael Johnson and Harvey Feigenbaum",
year = "1995",
doi = "10.1016/S0894-7317(05)80352-9",
language = "English",
volume = "8",
pages = "9--14",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Pharmacologically induced myocardial ischemia

T2 - A comparison of dobutamine and dipyridamole

AU - Segar, Douglas S.

AU - Ryan, Thomas

AU - Sawada, Stephen

AU - Johnson, Michael

AU - Feigenbaum, Harvey

PY - 1995

Y1 - 1995

N2 - The purpose of our study was to compare the ability of dobutamine and dipyridamole infusion to induce myocardial ischemia. In a population of 16 anesthetized open-chest swine, a coronary artery stenosis sufficient to abolish the hyperemic response to a 15-second total occlusion was created. Heart rate, systolic blood pressure, and dP/dt were recorded. Myocardial segment shortening was determined by sonomicrometry in all animals. In a subset of seven animals regional myocardial blood flow was measured by injection of radiolabeled microspheres. Dipyridamole was infused according to a high-dose protocol. After a washout period and reestablishment of a baseline state, dobutamine was infused incrementally. There was no significant difference between the baseline states. Dipyridamole did not affect heart rate but did significantly decrease blood pressure and rate-pressure product. Myocardial segment shortening decreased in the ischemic zone by 0.07±0.08 (p=0.004). Dobutamine infusion significantly increased heart rate, blood pressure, and rate-pressure product. Myocardial segment shortening in the ischemic zone decreased by 0.17±0.09 (p<0.001). Dobutamine decreased blood flow in the ischemic zone relative to baseline. Both dobutamine and dipyridamole infusion resulted in myocardial ischemia. The magnitude of the ischemic response is greater for dobutamine than for dipyridamole.

AB - The purpose of our study was to compare the ability of dobutamine and dipyridamole infusion to induce myocardial ischemia. In a population of 16 anesthetized open-chest swine, a coronary artery stenosis sufficient to abolish the hyperemic response to a 15-second total occlusion was created. Heart rate, systolic blood pressure, and dP/dt were recorded. Myocardial segment shortening was determined by sonomicrometry in all animals. In a subset of seven animals regional myocardial blood flow was measured by injection of radiolabeled microspheres. Dipyridamole was infused according to a high-dose protocol. After a washout period and reestablishment of a baseline state, dobutamine was infused incrementally. There was no significant difference between the baseline states. Dipyridamole did not affect heart rate but did significantly decrease blood pressure and rate-pressure product. Myocardial segment shortening decreased in the ischemic zone by 0.07±0.08 (p=0.004). Dobutamine infusion significantly increased heart rate, blood pressure, and rate-pressure product. Myocardial segment shortening in the ischemic zone decreased by 0.17±0.09 (p<0.001). Dobutamine decreased blood flow in the ischemic zone relative to baseline. Both dobutamine and dipyridamole infusion resulted in myocardial ischemia. The magnitude of the ischemic response is greater for dobutamine than for dipyridamole.

UR - http://www.scopus.com/inward/record.url?scp=0029193425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029193425&partnerID=8YFLogxK

U2 - 10.1016/S0894-7317(05)80352-9

DO - 10.1016/S0894-7317(05)80352-9

M3 - Article

C2 - 7710756

AN - SCOPUS:0029193425

VL - 8

SP - 9

EP - 14

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 1

ER -